Search - tctmd.com

Displaying 141 - 160 of 232

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Presenter: Eberhard Grube, Tamim Nazif, Hemal Gada

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Presenter: Eberhard Grube, Tamim Nazif, Chetan P. Huded

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Presenter: Eberhard Grube, Tamim Nazif, Alexandra J. Lansky

June 21, 2018

Presentation SCAI 2018

Cerebral Embolic Protection: Protect Everyone

Presenter: Samir Kapadia

April 28, 2018

Presentation SCAI 2018

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Presenter: Steven J Yakubov

April 28, 2018

Update on Mitral Valve Disease and Transcatheter Therapies for Non-Aortic Valves

Presentation Fellows 2018

Cerebral Embolic Protection: A New Standard of Care?

Presenter: Susheel K. Kodali

April 15, 2018

Presentation JIM 2018

The EMBLOK Embolic Protection System Early Feasibility and Safety Study: Preliminary Results

Presenter: Azeem Latib

February 23, 2018

Presentation JIM 2018

Prime Time For..."Protected TAVI"

Presenter: Martin B. Leon

February 23, 2018

Presentation ISET 2018

Best Techniques in 2018 for CAS Performance at Low Risk

Presenter: Chris Metzger

February 04, 2018

Presentation ISET 2018

Embolic Protection During CAS: Filters, Occlusion and Flow Reversals

Presenter: Claudio Schonholz

February 04, 2018

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Presenter: Martin B. Leon, Changfu Wu, John C Laschinger

October 31, 2017

Presentation TCT 2017

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Presenter: Martin B. Leon, Changfu Wu

October 31, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Presentation TCT 2017

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Presentation TCT 2017

Atherotomy, Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Robert T. Pyo

October 29, 2017

Presentation

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll,

October 06, 2017

Advertisement

Ulm University (Germany)

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Cerebral Embolic Protection: Protect Everyone

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Cerebral Embolic Protection: A New Standard of Care?

The EMBLOK Embolic Protection System Early Feasibility and Safety Study: Preliminary Results

Prime Time For..."Protected TAVI"

Best Techniques in 2018 for CAS Performance at Low Risk

Embolic Protection During CAS: Filters, Occlusion and Flow Reversals

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Atherotomy, Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content